Loading clinical trials...
Loading clinical trials...
Effectiveness and Tolerability of Lasmiditan as Acute Migraine Treatment: a Prospective, Multicentric, Cohort Study
Conditions
Interventions
Lasmiditan
Locations
2
Italy
SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
Florence, Italy
IRCCS National Neurological Institute "C. Mondino" Foundation
Pavia, Italy
Start Date
June 15, 2023
Primary Completion Date
June 1, 2024
Completion Date
December 1, 2025
Last Updated
January 21, 2026
NCT06735833
NCT06241313
NCT06810505
NCT07071506
NCT06641466
NCT07018713
Lead Sponsor
University of Florence
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions